Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid Leukemia.

Saved in:
Bibliographic Details
Title: Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid Leukemia.
Authors: Kotini AG; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York., Carcamo S; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; Bioinformatics for Next-Generation Sequencing Shared Resource Facility, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Cruz-Rodriguez N; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York., Olszewska M; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York., Wang T; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York., Demircioglu D; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; Bioinformatics for Next-Generation Sequencing Shared Resource Facility, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Chang CJ; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York., Bernard E; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Chao MP; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California., Majeti R; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California.; Cancer Institute, Stanford University School of Medicine, Stanford, California.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California., Luo H; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, New York.; Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center, New York, New York.; Center for Experimental Therapeutics, Memorial Sloan Kettering Cancer Center, New York, New York., Kharas MG; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, New York.; Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center, New York, New York.; Center for Experimental Therapeutics, Memorial Sloan Kettering Cancer Center, New York, New York., Hasson D; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; Bioinformatics for Next-Generation Sequencing Shared Resource Facility, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Papapetrou EP; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
Source: Blood cancer discovery [Blood Cancer Discov] 2023 Jul 05; Vol. 4 (4), pp. 318-335.
Publication Type: Editorial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Comment
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2643-3249
DOI:10.1158/2643-3230.BCD-22-0167